Page last updated: 2024-08-26

sr141716 and Anxiety

sr141716 has been researched along with Anxiety in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (4.65)18.2507
2000's19 (44.19)29.6817
2010's20 (46.51)24.3611
2020's2 (4.65)2.80

Authors

AuthorsStudies
Dean, R; Hamilton, TJ; Hudson, J; Johnson, AL; Verbitsky, R1
Cinar, R; Gao, B; Godlewski, G; Gunduz-Cinar, O; Herrerias, A; Iyer, MR; Kunos, G; Lin, Y; Santos-Molina, L; Wood, CM; Zawatsky, CN1
Anthenelli, RM; Aubin, HJ; Cinciripini, PM; Dale, LC; Karam-Hage, M; Niaura, R; Robinson, JD1
Genewsky, A; Heinz, DE; Wotjak, CT1
Conger, JR; Gamble-George, JC; Gupta, P; Hartley, ND; Patel, S; Sumislawski, JJ1
Blasio, A; Cottone, P; Di Marzo, V; Iannotti, FA; Iemolo, A; Orlando, P; Petrosino, S; Rice, KC; Sabino, V; Steardo, L; Zorrilla, EP1
Arrais, KC; Bergamaschi, MM; Chagas, MH; Crippa, JA; de Oliveira, DC; Hallak, JE; Huestis, MA; Linares, IM; Moreira, FA; Nardi, AE; Queiroz, ME; Queiroz, RH; Zuardi, AW1
Blasio, A; Cottone, P; Rice, KC; Sabino, V1
Benyhe, S; Borsodi, A; Csibrány, B; Klivényi, P; Lénárt, N; Marton, A; Molnár, M; Nagy, GM; Páldy, E; Samavati, R; Sántha, M; Tuka, B; Vécsei, L; Vizler, C; Zádor, F1
Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Longo, BM; Marinho, EA; Oliveira-Lima, AJ; Patti, CL; Santos, R; Takatsu-Coleman, AL; Wuo-Silva, R; Yokoyama, TS1
Campolongo, P; Cuomo, V; Hill, MN; Manduca, A; Morena, M; Palmery, M; Servadio, M; Trabace, L; Trezza, V; Vanderschuren, LJ1
McCool, BA; McGinnis, MM; Morales, M1
Antoniou, K; Delis, F; Gueye, AB; Laviolette, SR; Le Foll, B; Loureiro, M; Makriyannis, A; Poulia, N; Pryslawsky, Y; Trigo, JM; Vemuri, K1
Di, S; Fisher, MO; Gilpin, NW; Itoga, CA; Roltsch, EA; Solomonow, J; Tasker, JG1
Anderson, C; DiBerto, J; Duffy, K; Falls, WA; Fox, JH; Hammack, SE; Hardaway, JA; Hurd, YL; Kash, TL; Magness, ST; Mazzone, CM; McElligott, ZA; McKlveen, JM; Michaelides, M; Pati, D; Tipton, G1
Hasenöhrl, RU; Ledent, C; Molleman, A; Thiemann, G; Watt, CA1
Biala, G; Budzynska, B; Kruk, M1
Baarendse, PJ; Trezza, V; Vanderschuren, LJ1
Huang, P; Kirby, LG; Liu-Chen, LY1
Hohmann, AG; Sciolino, NR; Zhou, W1
Bialuk, I; Winnicka, MM1
Abou-El-Ela, SH; El-Wakeil, AF; Zaitone, SA1
Gyertyán, I; Kassai, F; Varga, B1
Adan, RA; Meye, FJ; Ramakers, GM; Trezza, V; Vanderschuren, LJ1
Dashney, B; Limebeer, CL; O'Brien, LD; Parker, LA; Rock, EM; Segsworth, B; Wills, KL1
Berrendero, F; Maldonado, R1
Bakos, N; Freund, TF; Haller, J; Ledent, C; Szirmay, M1
Calignano, A; Cuomo, V; Duranti, A; Fegley, D; Gaetani, S; Giustino, A; Kathuria, S; La Rana, G; Mor, M; Palmery, M; Piomelli, D; Tarzia, G; Tattoli, M; Tontini, A; Valiño, F1
Halasz, J; Haller, J; Mikics, E; Rodgers, RJ1
Assini, FL; Ramos, GA; Takahashi, RN1
Degroot, A; Nomikos, GG1
Fernandes, MS; Pamplona, FA; Takahashi, RN1
Marx, J1
Gadde, KM1
Ben-Shabat, S; Fride, E; Gobshtis, N1
Kaiser, N; Lutz, B; Monory, K; Moreira, FA1
Areda, T; Kõks, S; Raud, S; Reimets, A; Sütt, S; Vasar, E1
Mitchell, PB; Morris, MJ1
Al-Zaman, Y; Aylwin, S1
de Miguel, R; Fernández-Ruiz, J; Maestro, B; Michael Walker, J; Ramos, JA; Rubio, M1
Carrera, MR; del Arco, I; Hernández, E; Muñoz, RM; Navarro, M; Rodríguez de Fonseca, F; Villanúa, MA1
Carrera, MR; Koob, GF; Navarro, M; Rodríguez de Fonseca, F; Weiss, F1
Arévalo, C; de Miguel, R; Hernández-Tristán, R1

Reviews

1 review(s) available for sr141716 and Anxiety

ArticleYear
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide

2008

Trials

3 trial(s) available for sr141716 and Anxiety

ArticleYear
Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation.
    Addiction biology, 2018, Volume: 23, Issue:1

    Topics: Adult; Anorexia; Anxiety; Cannabinoid Receptor Antagonists; Cigarette Smoking; Diarrhea; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Rimonabant; Smoking Cessation; Vomiting

2018
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.
    Human psychopharmacology, 2014, Volume: 29, Issue:1

    Topics: Adult; Anxiety; Blood Pressure; Cannabinoid Receptor Antagonists; Double-Blind Method; Female; Heart Rate; Humans; Male; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Speech; Young Adult

2014
Depression and anxiety with rimonabant.
    Lancet (London, England), 2007, Nov-17, Volume: 370, Issue:9600

    Topics: Anti-Obesity Agents; Anxiety; Depression; Humans; Meta-Analysis as Topic; Piperidines; Pyrazoles; Rimonabant

2007

Other Studies

39 other study(ies) available for sr141716 and Anxiety

ArticleYear
Cannabinoid type-2 receptors modulate terpene induced anxiety-reduction in zebrafish.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 168

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Cannabinoids; Humans; Receptors, Cannabinoid; Rimonabant; Terpenes; Zebrafish

2023
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
    Molecules (Basel, Switzerland), 2021, Aug-22, Volume: 26, Issue:16

    Topics: Alcohol Drinking; Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Catalepsy; Cyclohexanols; Elevated Plus Maze Test; Endotoxemia; Endotoxins; Ethanol; Gastrointestinal Tract; Hypothermia, Induced; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stereoisomerism; Sulfonamides

2021
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle.
    Neuropharmacology, 2017, Volume: 126

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Avoidance Learning; Behavior, Animal; Benzamides; Benzodioxoles; Cannabinoid Receptor Agonists; Carbamates; Diazepam; Endocannabinoids; Fear; Male; Mice, Inbred C57BL; Monoacylglycerol Lipases; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2017
Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
    Psychopharmacology, 2013, Volume: 228, Issue:3

    Topics: Animals; Anxiety; Cannabinoid Receptor Antagonists; Consummatory Behavior; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stress, Psychological

2013
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:12

    Topics: Amygdala; Animals; Anorexia; Anti-Obesity Agents; Anxiety; Arachidonic Acids; Body Weight; Cannabinoid Receptor Antagonists; Corticosterone; Diet; Dietary Sucrose; Endocannabinoids; Female; Glycerides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant

2013
Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior.
    Behavioural pharmacology, 2014, Volume: 25, Issue:7

    Topics: Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feeding and Eating Disorders; Female; Maze Learning; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant

2014
Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Neuropharmacology, 2015, Volume: 89

    Topics: Adaptation, Ocular; Analgesics, Opioid; Animals; Anxiety; Cannabinoid Receptor Antagonists; CHO Cells; Cricetulus; Disease Models, Animal; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Narcotic Antagonists; Piperidines; Prosencephalon; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, kappa; Rimonabant; Swimming

2015
Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2015, Apr-03, Volume: 58

    Topics: Akathisia, Drug-Induced; Animals; Animals, Outbred Strains; Anxiety; Cannabinoid Receptor Antagonists; Central Nervous System Depressants; Cocaine; Depression; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Morphine; Motor Activity; Narcotics; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders

2015
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:8

    Topics: Aging; Animals; Anxiety; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Carbamates; Endocannabinoids; Exploratory Behavior; Glycerides; Male; Piperazines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats, Sprague-Dawley; Rimonabant; Social Behavior

2015
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats.
    Pharmacology, biochemistry, and behavior, 2015, Volume: 139, Issue:Pt A

    Topics: Alcohol Drinking; Animals; Anxiety; Choice Behavior; Dose-Response Relationship, Drug; Drinking; Ethanol; Female; Male; Maze Learning; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Sex Characteristics

2015
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:12

    Topics: Animals; Anxiety; Behavior, Addictive; Behavior, Animal; Cannabinoid Receptor Antagonists; Cues; Depression; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Inverse Agonism; Drug-Seeking Behavior; Male; Maze Learning; Mesencephalon; Motivation; Motor Activity; Piperidines; Pyrazoles; Rats, Long-Evans; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Swimming; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Weight Loss

2016
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 08-10, Volume: 36, Issue:32

    Topics: Animals; Antiemetics; Anxiety; Arachidonic Acids; Basolateral Nuclear Complex; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dexamethasone; Disease Models, Animal; Endocannabinoids; Enzyme Inhibitors; Glucocorticoids; Glycerides; Inhibitory Postsynaptic Potentials; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Restraint, Physical; Rimonabant; Synaptic Transmission

2016
Acute engagement of G
    Molecular psychiatry, 2018, Volume: 23, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain Mapping; Cannabinoid Receptor Antagonists; Clozapine; Dark Adaptation; Disease Models, Animal; Estrenes; Excitatory Postsynaptic Potentials; Exploratory Behavior; Green Fluorescent Proteins; GTP-Binding Protein alpha Subunits, Gq-G11; In Vitro Techniques; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Phosphodiesterase Inhibitors; Piperazines; Pyrrolidinones; Receptors, Drug; Rimonabant; RNA, Messenger; Septal Nuclei; Serotonin Receptor Agonists; Signal Transduction; Sodium Channel Blockers; Tetrodotoxin; Vesicular Inhibitory Amino Acid Transport Proteins

2018
Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
    Behavioural brain research, 2009, Jun-08, Volume: 200, Issue:1

    Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Biogenic Amines; Brain Chemistry; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Locomotion; Male; Maze Learning; Mice; Mice, Knockout; Piperidines; Prosencephalon; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Statistics as Topic

2009
Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2009, Volume: 60, Issue:2

    Topics: Animals; Anxiety; Benzoxazines; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Ligands; Male; Maze Learning; Mice; Morpholines; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant

2009
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:12

    Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior

2009
Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze.
    Neuroscience letters, 2010, May-21, Volume: 475, Issue:3

    Topics: Animals; Anxiety; Dronabinol; Emotions; Male; Maze Learning; Mice; Mice, Inbred ICR; Piperidines; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome

2010
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
    Pharmacological research, 2011, Volume: 64, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Modulators; Catalepsy; Diazepam; Endocannabinoids; Glycerides; Male; Monoacylglycerol Lipases; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction

2011
AM251, cannabinoids receptors ligand, improves recognition memory in rats.
    Pharmacological reports : PR, 2011, Volume: 63, Issue:3

    Topics: Animals; Anxiety; Dose-Response Relationship, Drug; Male; Maze Learning; Motor Activity; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Recognition, Psychology; Rimonabant

2011
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
    Behavioural pharmacology, 2012, Volume: 23, Issue:4

    Topics: Acetaminophen; Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Maze Learning; Mice; Mice, Inbred BALB C; Motor Activity; Piperidines; Pyrazoles; Rimonabant

2012
Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats.
    Pharmacology, biochemistry, and behavior, 2012, Volume: 103, Issue:2

    Topics: Animals; Anxiety; Disease Models, Animal; Fear; Feeding Behavior; Male; Memory; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant; Thiazoles

2012
Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity.
    Molecular psychiatry, 2013, Volume: 18, Issue:12

    Topics: Amygdala; Animals; Anxiety; Dopaminergic Neurons; Eating; GABAergic Neurons; Humans; Male; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Ventral Tegmental Area; Weight Gain

2013
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:3

    Topics: Animals; Anxiety; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Inverse Agonism; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Saccharin; Taste; Taste Perception

2013
Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
    Psychopharmacology, 2002, Volume: 163, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Darkness; Dronabinol; Endorphins; Light; Male; Mice; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Rimonabant

2002
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
    The European journal of neuroscience, 2002, Volume: 16, Issue:7

    Topics: Animals; Anxiety; Exploratory Behavior; Maze Learning; Mice; Mice, Knockout; Motor Activity; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

2002
Modulation of anxiety through blockade of anandamide hydrolysis.
    Nature medicine, 2003, Volume: 9, Issue:1

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Behavior, Animal; Cannabinoids; Cells, Cultured; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Molecular Structure; Neurons; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Radioligand Assay; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vocalization, Animal

2003
'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze.
    The European journal of neuroscience, 2003, Volume: 17, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cannabinoid Receptor Modulators; Chlordiazepoxide; Male; Maze Learning; Mice; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

2003
Anxiety does not affect the antinociceptive effect of Delta 9-THC in mice: participation of cannabinoid and opioid receptors.
    Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:4

    Topics: Animals; Anxiety; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Opioid; Rimonabant

2003
Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test.
    The European journal of neuroscience, 2004, Volume: 20, Issue:4

    Topics: Animals; Anxiety; Carbolines; Chlordiazepoxide; Electroshock; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2004
The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.
    Neuroscience letters, 2005, Jun-03, Volume: 380, Issue:3

    Topics: Animals; Anxiety; Cannabinoid Receptor Modulators; Drug Interactions; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Neural Pathways; Neurons; Nootropic Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Scopolamine

2005
Drug development. Drugs inspired by a drug.
    Science (New York, N.Y.), 2006, Jan-20, Volume: 311, Issue:5759

    Topics: Animals; Anti-Obesity Agents; Anxiety; Arachidonic Acids; Blood Pressure; Brain; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Endocannabinoids; Humans; Inflammation; Neurons; Obesity; Osteoporosis; Pain; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Smoking Cessation

2006
Effect of rimonabant on weight and cardiometabolic risk factors.
    JAMA, 2006, Aug-09, Volume: 296, Issue:6

    Topics: Anti-Obesity Agents; Anxiety; Depression; Humans; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Risk Factors

2006
Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness.
    European journal of pharmacology, 2007, Jan-12, Volume: 554, Issue:2-3

    Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Desipramine; Female; Fluoxetine; Maze Learning; Mice; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Swimming; Time Factors; Weight Gain

2007
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Neuropharmacology, 2008, Volume: 54, Issue:1

    Topics: Amidohydrolases; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Disease Models, Animal; Endocannabinoids; Glycerides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2008
Cat odour-induced anxiety--a study of the involvement of the endocannabinoid system.
    Psychopharmacology, 2008, Volume: 198, Issue:4

    Topics: Amidohydrolases; Amygdala; Animals; Anxiety; Cannabinoid Receptor Modulators; Cats; DNA, Complementary; Endocannabinoids; Exploratory Behavior; Limbic System; Male; Motor Activity; Odorants; Periaqueductal Gray; Phospholipase D; Piperidines; Predatory Behavior; Pyrazoles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA

2008
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Neuropharmacology, 2008, Volume: 54, Issue:6

    Topics: Animals; Anxiety; Appetite; Arachidonic Acids; Autoradiography; Benzoxazines; Brain Chemistry; Cannabinoid Receptor Modulators; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Emotions; Endocannabinoids; Enkephalins; Ethanol; Ethanolamines; Glycerides; In Situ Hybridization; Male; Morpholines; Motor Activity; Naphthalenes; Neuropeptide Y; Neurotransmitter Agents; Piperidines; Polyunsaturated Alkamides; Protein Precursors; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Stress, Psychological; Substance Withdrawal Syndrome

2008
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
    Neuroreport, 1997, Jan-20, Volume: 8, Issue:2

    Topics: Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors

1997
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
    Science (New York, N.Y.), 1997, Jun-27, Volume: 276, Issue:5321

    Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain; Corticosterone; Corticotropin-Releasing Hormone; Dronabinol; Male; Microdialysis; Piperidines; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Substance Withdrawal Syndrome

1997
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.
    Pharmacology, biochemistry, and behavior, 2001, Volume: 70, Issue:1

    Topics: Analgesics; Animals; Anxiety; Cannabinoids; Cyclohexanols; Drug Therapy, Combination; Exploratory Behavior; Hypothalamus; Male; Motor Activity; Neurotransmitter Agents; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant

2001